Enalare Therapeutics, INC.
Biopharmaceutical company
Based in NJ
🤖
AI Overview
With $10K in lobbying spend across 8 quarterly filings, Enalare Therapeutics, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2023.
$10K
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $0 |
| 2022 | $10K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Defense
- •Discussion of DoD funding of drug therapy research
- •Meetings with officials regarding the relevance of respiratory stimulants to the DOD.
- •National Defense Authorization Act for FY23, provisions relating to the relevance of respiratory stimulants to the DOD.
- •HR 7900 National Defene Authorization Act for FY23, proviion relating to respiratory stimulants.
- •HR 7900 National Defense Authorization Act for FY23, provision relating to respiratory stimulants.
Related Analysis
Related Investigations
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.